Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-18

Clinical Trial Update: Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing caspofungin acetate to liposomal amphotericin B in cancer patients with persistent fever and neutropenia after cancer treatment has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphotericin B Liposomal (amphotericin B liposomal)
  • Caspofungin Acetate (caspofungin acetate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cancer | Phase 3 | Status: COMPLETED